|Professor, The Wilmer Eye Institute|
The Johns Hopkins Hospital, Wilmer 120
600 North Wolfe Street
Baltimore, MD 21287
Academic Office: 410-614-1342
David S. Friedman, M.D., M.P.H., Ph.D. is the Alfred Sommer Professor at the Wilmer Eye Institute of Johns Hopkins University School of Medicine and is also a Professor in the Department of International Health at Johns Hopkins Bloomberg School of Public Health. He graduated summa cum laude from Yale College, received his medical degree from Harvard Medical School (1992), and obtained a doctorate in Epidemiology from Johns Hopkins (2007). He completed his residency at Wills Eye Hospital and served as a glaucoma fellow at Wilmer.
Dr. Friedman is world renowned for his contributions to the study of the mechanisms, epidemiology and prevention of angle-closure glaucoma. He has also made important contributions in the area of medication adherence and was the principal investigator in the first trial to show that an intervention can successfully improve patient use of eye medicines. He is a highly valued glaucoma specialist and cataract surgeon, receiving referrals from the region and overseas. He is innovative clinically and is currently offering one of the newest glaucoma surgeries, the Trabectome procedure.
Dr. Friedman also runs the glaucoma fellowship training program and assists residents with their clinics and in the operating room. His current research in angle-closure glaucoma is being conducted through clinical trials in south China, where it is very common. He is fluent in Mandarin, proficient in Medical Spanish and speaks some Indonesian.
Dr. Friedman is the recipient of various awards from the National Institutes of Health, Research to Prevent Blindness and American Geriatric Society. He obtained grants from the Glaucoma Research Foundation to study glaucoma genetics and from Johns Hopkins-Singapore to identify novel risk factors for angle-closure glaucoma. He was the recipient of the Douglas Jahnigen Clinician Scientist Award from the American Geriatrics Society. He has also obtained substantial funding to support research in patient adherence to glaucoma medications. He co-edited a definitive book on angle-closure glaucoma and has published nearly 150 articles. He serves on the editorial boards of Ophthalmology and the Journal of Glaucoma, plays a leadership role in the World Glaucoma Association and the American Glaucoma Society, and recently became the Senior Ophthalmologist for Helen Keller International, a large non-profit organization dedicated to alleviating blindness worldwide.
Dr. Friedman was selected to give the Mohammad Aziz lecture at Johns Hopkins, the E.B. Spaeth lecture at Wills Eye Hospital and to be the Hong Leung Visiting Professor at National University of Singapore. He was recently a keynote speaker at the European Glaucoma Society annual meeting and is invited regularly to present invited talks at major ophthalmologic meetings.
Dr. Friedman chose to become a doctor in the senior year of college and had to spend an extra year completing required classes to go to medical school. He dedicated himself at that time to providing care to those who are in need and continues to do so through his work with patients in the clinic as well as through his eye care development activities in poorer countries. Dr. Friedman notes: “I’ve been incredibly fortunate. The work I do is exactly what I hoped to do when I started medical school. I wanted to care for patients, to have the opportunity to research, and to do development work internationally. And I’m doing all three.”